Article Versions Notes

Beutel AK, Schütte L, Scheible J, Roger E, Müller M, Perkhofer L, Kestler AMTU, Kraus JM, Kestler HA, Barth TFE, et al. A Prospective Feasibility Trial to Challenge Patient–Derived Pancreatic Cancer Organoids in Predicting Treatment Response. Cancers. 2021; 13(11):2539. https://doi.org/10.3390/cancers13112539

Beutel, Alica K., Lena Schütte, Jeanette Scheible, Elodie Roger, Martin Müller, Lukas Perkhofer, Annika M. T. U. Kestler, Johann M. Kraus, Hans A. Kestler, Thomas F. E. Barth, and et al. 2021. "A Prospective Feasibility Trial to Challenge Patient–Derived Pancreatic Cancer Organoids in Predicting Treatment Response" Cancers 13, no. 11: 2539. https://doi.org/10.3390/cancers13112539

Beutel, A. K., Schütte, L., Scheible, J., Roger, E., Müller, M., Perkhofer, L., Kestler, A. M. T. U., Kraus, J. M., Kestler, H. A., Barth, T. F. E., Lemke, J., Kornmann, M., Ettrich, T. J., Gout, J., Seufferlein, T., & Kleger, A. (2021). A Prospective Feasibility Trial to Challenge Patient–Derived Pancreatic Cancer Organoids in Predicting Treatment Response. Cancers, 13(11), 2539. https://doi.org/10.3390/cancers13112539